Skip to main content
. 2017 Nov;38(11):2138–2145. doi: 10.3174/ajnr.A5404

Table 1:

Univariate analysis in the atherothrombotic tandem occlusion group

mRS 0–2 (n = 27) No. (%) or (Mean) mRS >2 (n = 38) No. (%) or (Mean) P Value
Age (yr) 27 (64.6 ± 8.1) 38 (69.2 ± 10.6) .04
Men 27 (0.9 ± 0.3) 38 (0.9 ± 0.3) .47
Hypertension 21 (77.8) 27 (71.1) .58
Cigarette smoking 11 (40.7) 21 (55.3) .32
Dyslipidemia 19 (70.4) 19 (50) .13
Diabetes 11 (40.7) 14 (36.8) .80
Other cardiovascular risk factors 2 (7.4) 9 (23.7) .11
Left side 13 (48.1) 27 (71.1) .08
Distal ICA occlusion 8 (29.6) 22 (57.9) .04
Baseline NIHSS score 27 (14.9 ± 6.3) 38 (18.9 ± 5.2) .005
Baseline DWI–ASPECTS 27 (7.1 ± 1.7) 37 (6.7 ± 1.5) .22
IV rtPA 16 (59.3) 24 (63.2) .80
Onset-reperfusion time (min) 24 (377 ± 147.3) 32 (390.4 ± 173.4) .93
Procedural time (min) 25 (76.6 ± 39.1) 33 (85.8 ± 48.5) .49
Number of stent retriever passes 27 (1.9 ± 0.9) 37 (2.5 ± 1.2) .03
Acute stenting 10 (37) 15 (39.5) 1
Procedural complications 5 (18.5) 17 (44.7) .04
Ischemic extension 2 (7.4) 19 (50) <.001
Hemorrhagic transformation 8 (29.6) 23 (60.5) .02
    Subarachnoid hemorrhage 1 (3.7) 4 (10.5) .39
    H-1 3 (11.1) 3 (7.9) .69
    H-2 4 (14.8) 7 (18.4) .75
    PH-1 0 (0) 3 (7.9) .26
    PH-2 0 (0) 7 (18.4) .04
    sICH 0 (0) 10 (26.3) .004
TICI 2b/3 25 (92.6) 16 (42.1) <.001